{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Supriya Lifescience Ltd
Supriya Lifescience Technical Momentum Shifts Amid Mixed Market Signals
Supriya Lifescience has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and neutral signals across key indicators. The stock’s recent price movements and technical parameters suggest evolving market sentiment within the Pharmaceuticals & Biotechnology sector.
Supriya Lifescience Technical Momentum Shifts Amid Mixed Indicator Signals
Supriya Lifescience, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of indicator signals across multiple timeframes. Recent market data reveals a transition from a bullish to a mildly bullish trend, with mixed signals from MACD, RSI, and moving averages suggesting a cautious outlook for investors.
Supriya Lifesci. Sees Revision in Market Evaluation Amid Mixed Financial Signals
Supriya Lifesci., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting a nuanced shift in its financial and technical outlook. This adjustment comes amid a backdrop of steady management efficiency, valuation concerns, and a mixed performance trend over recent periods.
Why is Supriya Lifesci. falling/rising?
On 21-Nov, Supriya Lifescience Ltd experienced a notable decline in its share price, falling by 3.68% to close at ₹743.75. This drop reflects a broader short-term underperformance relative to market benchmarks and sector peers, despite the company’s strong long-term track record and solid financial fundamentals.
Why is Supriya Lifesci. falling/rising?
As of 13-Nov, Supriya Lifescience Ltd's stock price is Rs 785.50, reflecting a 3.16% increase. The stock has shown strong performance with a total return of 5.68% over the last two days and impressive annual returns of 27.66%, outperforming the BSE500 index.
Supriya Lifescience Reports Record Financial Performance Amidst Market Fluctuations
Supriya Lifescience has reported strong financial results for the quarter ending September 2025, achieving record net sales, PBDIT, and profit after tax. The company has shown resilience in the market, outperforming the Sensex in various timeframes, indicating effective navigation of its market position and robust operational performance.
Supriya Lifescience Hits Day High with 7.93% Surge in Strong Performance
Supriya Lifescience has experienced notable gains today, reaching an intraday high and outperforming its sector. The small-cap pharmaceutical company has shown consistent growth over the past two days, with strong market momentum reflected in its trading above key moving averages. The broader market also shows positive trends.
How has been the historical performance of Supriya Lifesci.?
Supriya Lifesci has shown significant growth from March 2020 to March 2025, with net sales increasing from 311.64 Cr to 696.49 Cr, and profit after tax rising from 73.37 Cr to 187.96 Cr. The company's total assets also grew from 336.15 Cr to 1,112.31 Cr, indicating strong overall financial performance.
Why is Supriya Lifesci. falling/rising?
As of 11-Nov, Supriya Lifescience Ltd's stock price is Rs 745.50, down 1.34%, and has fallen 5.48% over the last two days. Despite a strong long-term performance, recent declines and reduced investor participation suggest short-term challenges.
Why is Supriya Lifesci. falling/rising?
As of 03-Nov, Supriya Lifescience Ltd's stock price is Rs 782.80, up 0.93%, and has gained 4.98% over the last three days. The stock has outperformed the broader market with a 23.04% return over the past year and a significant 174.23% over the last three years, supported by strong management efficiency and low debt.
Is Supriya Lifesci. technically bullish or bearish?
As of October 23, 2025, Supriya Lifesci's technical trend is bullish, supported by strong indicators like the weekly MACD, Bollinger Bands, and moving averages, despite a mildly bearish monthly MACD.
Supriya Lifescience Shows Mixed Technical Trends Amid Strong Market Performance
Supriya Lifescience, a small-cap pharmaceutical company, has shown impressive performance with a 39.36% return over the past year, significantly surpassing the Sensex. Recent evaluations reflect mixed technical indicators, with bullish trends noted in various metrics, underscoring the company's strong market presence and growth potential.
Supriya Lifescience Forms Golden Cross, Signaling Bullish Breakout Ahead
Supriya Lifescience, a small-cap pharmaceutical company, has recently achieved a Golden Cross, indicating positive short-term momentum. The stock has outperformed the Sensex over the past year and three years, showcasing strong market performance. Technical indicators suggest continued investor interest as the company navigates the competitive landscape.
Supriya Lifescience Shows Shift in Market Sentiment Amid Mixed Technical Indicators
Supriya Lifescience, a small-cap pharmaceutical company, has experienced a shift in its technical evaluation, moving towards a more positive market sentiment. Key indicators show a mix of bullish trends, despite recent financial challenges, including declines in profit and net sales, while maintaining strong long-term performance metrics.
How has been the historical performance of Supriya Lifesci.?
Supriya Lifesci has shown consistent growth in net sales and profitability, with net sales increasing from 311.64 Cr in March 2020 to 696.49 Cr in March 2025, and profit after tax rising from 73.37 Cr to 187.96 Cr during the same period. The company also significantly improved its total assets, reaching 1,112.31 Cr by March 2025.
Is Supriya Lifesci. technically bullish or bearish?
As of October 17, 2025, the trend is mildly bullish due to weekly MACD and Bollinger Bands, but caution is advised due to a bearish weekly RSI and daily moving averages.
Supriya Lifescience Shows Mixed Technical Trends Amid Strong Yearly Performance
Supriya Lifescience, a small-cap pharmaceutical company, has recently seen its stock price rise, outperforming the Sensex over the past week. The stock has delivered impressive returns of 32.2% over the past year and 158.08% over three years, showcasing its growth potential in the industry.
Is Supriya Lifesci. technically bullish or bearish?
As of October 17, 2025, the trend has shifted to mildly bullish, supported by a bullish MACD and Bollinger Bands, despite a bearish weekly RSI and mildly bearish daily moving averages, indicating a mixed but positive outlook.
Is Supriya Lifesci. technically bullish or bearish?
As of October 17, 2025, the trend has shifted to mildly bullish, supported by bullish weekly MACD and KST indicators, despite mixed signals from the RSI and moving averages indicating a mildly bearish stance.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
